Jae-Hoon Chang Selected Research

Chemokines

1/2023	Liposomal co-delivery of toll-like receptors 3 and 7 agonists induce a hot triple-negative breast cancer immune environment.
10/2019	Regulatory T Cells Tailored with pH-Responsive Liposomes Shape an Immuno-Antitumor Milieu against Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jae-Hoon Chang Research Topics

Disease

15	Neoplasms (Cancer) 03/2024 - 01/2018
8	Inflammation (Inflammations) 01/2022 - 08/2011
6	Colitis 01/2023 - 07/2014
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 09/2010
4	Anaphylaxis (Anaphylactic Shock) 09/2019 - 01/2017
4	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 09/2010
3	Disease Progression 02/2017 - 01/2017
2	Breast Neoplasms (Breast Cancer) 09/2023 - 03/2020
2	Hyperplasia 02/2013 - 06/2010
1	Lung Neoplasms (Lung Cancer) 03/2024
1	Triple Negative Breast Neoplasms 01/2023
1	Adenocarcinoma 10/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Infections 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018
1	Necrosis 01/2018
1	Multiple Sclerosis 01/2018
1	Ulcerative Colitis 01/2018
1	Insulin Resistance 01/2018
1	Hypersensitivity (Allergy) 01/2017
1	Neuroinflammatory Diseases 01/2015
1	Immune System Diseases (Immune Disorders) 10/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2014
1	Edema (Dropsy) 07/2014

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2004
4	Dextran SulfateIBA 01/2021 - 01/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2023 - 12/2018
3	CytokinesIBA 12/2022 - 07/2014
3	Sirtuin 1IBA 01/2022 - 01/2017
3	AntigensIBA 01/2021 - 02/2013
2	AntibodiesIBA 03/2024 - 12/2022
2	Interferon Type IIBA 09/2023 - 01/2023
2	VaccinesIBA 09/2023 - 10/2014
2	ChemokinesIBA 01/2023 - 10/2019
2	InflammasomesIBA 01/2023 - 03/2020
2	AMP-Activated Protein KinasesIBA 01/2022 - 01/2017
2	LigandsIBA 08/2021 - 10/2019
2	Mevalonic Acid (Mevalonate)IBA 01/2021 - 01/2019
2	Interleukin-2 (IL2)IBA 01/2021 - 10/2019
2	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2018 - 01/2017
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2024
1	Messenger RNA (mRNA)IBA 03/2024
1	Bevacizumab (Avastin)FDA Link 03/2024
1	Peptides (Polypeptides)IBA 09/2023
1	HMGB1 Protein (HMG1)IBA 09/2023
1	CalreticulinIBA 09/2023
1	LTX-315IBA 09/2023
1	Methionine (L-Methionine)FDA Link 01/2023
1	S-Adenosylmethionine (Ademetionine)IBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2022
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 12/2022
1	RibonucleotidesIBA 01/2022
1	AICA ribonucleotide (ZMP)IBA 01/2022
1	maleimideIBA 12/2021
1	AcidsIBA 12/2021
1	Gemcitabine FDA Link 10/2021
1	serotonin 7 receptorIBA 10/2021
1	AlbuminsIBA 08/2021
1	geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	CholesterolIBA 01/2021
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Simvastatin (Zocor)FDA LinkGeneric 01/2021
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 01/2021
1	AdipokinesIBA 03/2020
1	NLR ProteinsIBA 03/2020
1	AdiponectinIBA 03/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 12/2019
1	PolymersIBA 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019
1	MicroRNAs (MicroRNA)IBA 12/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2019
1	Imiquimod (Aldara)FDA LinkGeneric 10/2019
1	Liposomes (Liposome)IBA 10/2019
1	sauchinoneIBA 09/2019
1	Orphan Nuclear ReceptorsIBA 01/2019
1	Member 1 Group A Nuclear Receptor Subfamily 4IBA 01/2019
1	Arachidonic Acid (Vitamin F)IBA 12/2018
1	IonophoresIBA 12/2018
1	salinomycinIBA 12/2018
1	tanshinoneIBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA 01/2018
1	BJ-1108IBA 02/2017
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2017
1	ResveratrolIBA 01/2017
1	BJ-2266IBA 01/2017
1	BJ-3105IBA 01/2017
1	InterferonsIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2015

Therapy/Procedure

6	Immunotherapy 09/2023 - 01/2018
5	Therapeutics 03/2024 - 01/2018
1	Drug Therapy (Chemotherapy) 08/2021
1	Microspheres (Microsphere) 12/2019